STEPHEN ROHRER: Open Payments
NPI 1538611975 · WYNNE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 48 payments from 18 companies in 2025. Trend: 2023 $1,972 · 2024 $543 · 2025 $1,397
Food & beverage: $1,397
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $214 |
| AstraZeneca Pharmaceuticals LP | 4 | $168 |
| Abbott Laboratories | 3 | $150 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $150 |
| Organogenesis Inc. | 3 | $147 |
| Amgen Inc. | 2 | $131 |
| ABBVIE INC. | 4 | $79 |
| Smith+Nephew, Inc. | 1 | $70 |
| Novo Nordisk Inc | 4 | $62 |
| Reprise Biomedical, Inc. | 3 | $50 |
Products named: SIMPLERA SENSOR, CARDIOMEMS, CAPLYTA, AIRSUPRA, SIMPLIMAX, REPATHA, STRAVIX PL, BREZTRI.
Industry payments across AR — which companies pay providers there.
